• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGalera Therapeutics
    Picture of Galera Therapeutics logo

    GRTX — Galera Therapeutics News Story

    $0.090.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSuper Stock
    • Market Cap
      $14.13m
    • Enterprise Value
      $8.63m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GRTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GRTX Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

    Picture of Galera Therapeutics logoGalera Therapeutics
    19/10/2021 11:55
    NASDAQ TRADE HALT  GRTX.O  HALT NEWS PENDING AT 06:55 AM
    

    Recent news on Galera Therapeutics

    See all news
    • Brief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4

      04/09/2024 12:30
    • Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution

      14/08/2024 12:10
    • Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares

      03/06/2024 13:35
    • Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics

      16/05/2024 15:28
    • Brief: Galera Adopts Limited Duration Stockholder Rights Agreement

      03/05/2024 12:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.